Latest news with #DeepSeek-style
Yahoo
08-04-2025
- Business
- Yahoo
Alibaba Just Fired a Global AI Warning Shot -- Silicon Valley Should Be Worried
Alibaba (NYSE:BABA) is stepping harder into the global AI gameand it's not playing small. This week, the company rolled out a beefed-up lineup of AI tools through its Singapore cloud zones, spotlighting two new large language models: Qwen-Max and the DeepSeek-style QwQ-Plus. It's part of a bigger strategy to win over international developers and businesses, fast. After China's AI industry sent shockwaves through Silicon Valley earlier this year with DeepSeek's ultra-cheap training costs, Alibaba is now pushing even harder to position itself as the low-cost, high-value alternative for global AI adoption. Warning! GuruFocus has detected 2 Warning Signs with BABA. The upgrades don't stop there. Alibaba's about to drop its next heavyweight: Qwen 3, its flagship model, reportedly launching this month. That follows a string of rapid-fire updates including a smarter Quark AI assistantnow loaded with chatbot, deep reasoning, and task execution features. While US tech giants fight for AI dominance, Alibaba's approach is clear: price it low, ship it fast, and build sticky tools for developers. The $1-a-year business intelligence platform for coders? That wasn't a stunt. It's a message: come build with us. Beyond tools for the builders, Alibaba is also moving upstreamchasing enterprise users with a new suite of SaaS products. AI Doc can parse everything from legalese to spreadsheets, while Smart Studio helps users spin up generative content with ease. Together, these moves signal Alibaba's next chapter: from cloud infrastructure player to full-stack AI platform. For investors, it's a high-conviction bet on whether Alibaba can translate deep tech innovation and aggressive pricing into global market shareand maybe, a much-needed narrative shift. This article first appeared on GuruFocus. Sign in to access your portfolio
South China Morning Post
07-02-2025
- Business
- South China Morning Post
As US and China dominate AI race, where is Europe's answer to DeepSeek and ChatGPT?
Europe has trailed the US and China in the AI race, and the rise of DeepSeek has only widened the gap, but open-source projects and regulatory efforts could help the continent carve its own path in artificial intelligence, according to tech experts. Advertisement Hangzhou-based start-up DeepSeek made headlines last month with two large language models – V3 and R1 – that have emerged as challengers to OpenAI's ChatGPT while requiring only a fraction of the cost and computing power to build. This has put China in a strong position in its AI rivalry with the United States and fuelled hopes for more DeepSeek-style disrupters But European tech firms have not yet produced an AI contender on the level of ChatGPT or DeepSeek. Neil Lawrence, a senior AI fellow at the London-based Alan Turing Institute, noted that Britain was 'a long way behind' the US and China in both the development and deployment of the technology. Advertisement 'Similar applies to most of Europe, but there are encouraging signs in Germany, France, Finland and Switzerland,' Lawrence said.
South China Morning Post
29-01-2025
- Science
- South China Morning Post
China's ‘artificial sun', breast cancer vaccine tests: 7 science highlights
Published: 3:00pm, 29 Jan 2025 We have put together stories from our science coverage from the past two weeks to help you stay informed. If you would like to see more of our reporting, please consider subscribing . Scientists in China on a quest to build a nuclear fusion reactor capable of producing unlimited, low-cost energy have achieved a sustained plasma temperature exceeding 100 million degrees Celsius (180 million Fahrenheit) for an unprecedented 1,066 seconds – a world record. 2. What will it take for China to produce the next DeepSeek-style disrupter? China is likely to produce more 'technological surprises', but an open innovation ecosystem is critical for gaining AI edge, analysts say. 3. Chinese team says vaccine shows promise in treating breast cancer in mice Nanovaccines derived from cell membranes are an emerging type of vaccine. Photo: Shutterstock Chinese scientists have developed a nanovaccine from tumour cell membranes that they say has shown promise in treating an aggressive form of breast cancer in mice.
